Clinical Manifestations of Behçet’s Disease: A Retrospective Cross-Sectional Study
Mediterranean Journal of Rheumatology · 2023 · 34 (1) · 53
DOI: 10.31138/mjr.34.1.53 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Mediterranean Journal of Rheumatology, 2023. Verfasst von Alireza Sadeghi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Vali-e-Asr Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Behçet's Disease (BD) is a systemic vasculitis, highly prevalent in Eastern Asia to Mediterranean countries. Iran is among the countries with the highest prevalence of BD, and previous studies in different countries have shown a broad range of clinical manifestations of the disease. The present study is conducted to evaluate the prevalence of the clinical manifestations of BD in patients referring to rheumatology clinics of two distinct referral hospitals in Tehran and Zanjan, Iran.
Methods
In this retrospective, cross-sectional study, the medical records of patients with BD were reviewed, and age at onset, sex, the delay between the onset of symptoms and diagnosis, clinical manifestations, HLA B27, HLA B51, HLA B5, haematuria, proteinuria, leukocyturia, Erythrocyte Sedimentation Rate (ESR), and pathergy phenomenon were included in the study. The collected data were analysed by χ2 test using SPSS 23.
Results
A total of 188 patients (Male/female ratio = 1.47) were included in the study with mean ± SD age at onset of 27.98 ± 10.47 years and a mean ± SD of delay between the onset of symptom and diagnosis of 5.70 ± 7.16 years. The most common clinical manifestation was mucosal involvement (85.1%), followed by the ocular lesion (55.3%) and skin manifestations (44.7%). The Pathergy phenomenon was observed in 98 patients (52.1%). Moreover, 45.2% had positive HLA B5, followed by HLA B51 (35.1%) and HLA B27 (12.2%).
Conclusion
This study demonstrated that male/female ratio and mean age at onset were comparable to the results of previous studies in Iran. Significant associations between HLAB5 and clinical manifestations underline the pivotal role of genetic factors in BD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Vali-e-Asr Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
- Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
- Behçet's Disease Unit, Rheumatology Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Ophthalmology, School of Medicine, Vali-E-Asr Hospital, Zanjan University of Medical sciences, Zanjan, Iran.
- Department of Radiation Oncology, Vali-e-Asr Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
- Department of Emergency Medicine, Valiasr-e-Asr Hospital, Ayatollah Mousavi Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Zitieren
APA
Sadeghi, A., Rostami, M., Amraei, G., Davatchi, F., Shahram, F., Karimi Moghaddam, A., Karimi Moghaddam, Z., & Zeraatchi, A. (2023). Clinical Manifestations of Behçet’s Disease: A Retrospective Cross-Sectional Study. Mediterranean Journal of Rheumatology, 34(1), 53. https://doi.org/10.31138/mjr.34.1.53
Vancouver
Sadeghi A, Rostami M, Amraei G, Davatchi F, Shahram F, Karimi Moghaddam A, et al. Clinical Manifestations of Behçet’s Disease: A Retrospective Cross-Sectional Study. Mediterranean Journal of Rheumatology. 2023;34(1):53. doi:10.31138/mjr.34.1.53
BibTeX
@article{Sadeghi2023,
author = {Sadeghi, Alireza and Rostami, Mina and Amraei, Ghazaleh and Davatchi, Fereydoun and Shahram, Farhad and Karimi Moghaddam, Arezoo and Karimi Moghaddam, Zhaleh and Zeraatchi, Alireza},
title = {Clinical Manifestations of Behçet’s Disease: A Retrospective Cross-Sectional Study},
journal = {Mediterranean Journal of Rheumatology},
year = {2023},
volume = {34},
number = {1},
pages = {53},
doi = {10.31138/mjr.34.1.53}
}
EUVIMED